FDA Recommends about Meridia (sibutramine)
ืื ืืฉื ืจืืืงืืื FDA- ื ืกืคื: ืืืืขืช ื (http://www.fda.gov/Drugs/DrugSafety/ucm228746.htm) ๏ท FDA Drug Safety Communication: FDA Recommends Against the Continued Use of Meridia (sibutramine) Safety Announcement [10-8-2010] The U.S. Food and Drug Administration (FDA) is recommending against continued prescribing and use of Meridi(sibutramine) because this drug may pose unnecessary cardiovascular risks to patients. FDA has requested that Abbott Laboratoriesโthe manufacturer of...
Read More